InsiderTrades

Form 4 for BEAM Beam Therapeutics Inc.

Accepted 2026-06-22 16:05:05 ET · period of report 2026-06-17 · accession 0001193125-26-277509 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-06-22 16:05 2026-06-17 BEAM Ciaramella Giuseppe Pres M - OptEx $0.964 +35.5K 253.9K +16% +$34.2K
DM 2026-06-22 16:05 2026-06-17 BEAM Ciaramella Giuseppe Pres M - OptEx $0.00 -35.5K 56.9K -38% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-17 M A 6,505 $0.67 224,911 D — —
2 Common Common Stock 2026-06-17 M A 29,000 $1.03 253,911 D — —
3 Derivative Stock Option (Right to Buy) 2026-06-17 M D 6,505 $0.00 0 D $0.67 · — to 2028-05-08 6,505 Common Stock (F1) The shares subject to these stock options vested 25% on the first anniversary of the vesting commencement dates, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter.
4 Derivative Stock Option (Right to Buy) 2026-06-17 M D 29,000 $0.00 56,946 D $1.03 · — to 2028-07-13 29,000 Common Stock (F1) The shares subject to these stock options vested 25% on the first anniversary of the vesting commencement dates, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter.